Amelioration of subacute camptocormia in multiple system atrophy by protirelin tartrate

Movement Disorders

Volumn 24, Issue 13, 2009, Pages 2022-2023

  Takei, Asako ^a   Hamada, Shinsuke ^a   Homma, Sanae ^a   Hamada, Keiko ^a   Tashiro, Kunio ^a   Hamada, Takeshi ^a  

^a Hokuyukai Neurology Hospital   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

LEVODOPA; PROTIRELIN TARTRATE; TRIHEXYPHENIDYL;

AGED; ARM DISEASE; CAMPTOCORMIA; CASE REPORT; CEREBELLAR ATAXIA; CLINICAL FEATURE; DISEASE ASSOCIATION; DISEASE COURSE; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; ELECTROMYOGRAPHY; FEMALE; HAND TREMOR; HOARSENESS; HUMAN; LABORATORY TEST; LEG DISEASE; LETTER; LIMB WEAKNESS; MOTOR NERVE CONDUCTION; MUSCLE RIGIDITY; NUCLEAR MAGNETIC RESONANCE IMAGING; PARKINSONISM; PATHOPHYSIOLOGY; PHYSICAL EXAMINATION; POLYURIA; PRIORITY JOURNAL; SHY DRAGER SYNDROME; SPASTICITY;

AGED; FEMALE; HORMONES; HUMANS; MULTIPLE SYSTEM ATROPHY; SPINAL CURVATURES; THYROTROPIN-RELEASING HORMONE;

EID: 70450179595     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.22699     Document Type: Letter

References (7)

1. Azher SN, Jankovic J. Camptocormia: pathogenesis, classification, and response to therapy. Neurology 2005;65:355-359. (Pubitemid 41099795)
2. Sohue I, Takayanagi T, Nakanishi T, et al. Controlled trial of thyrotropin releasing hormone tartrate in ataxia of spinocerebellar degenerations. J Neurol Sci 1983;61:235-248.
3. Miyamoto Y, Kikakawa R, Hatanaka I, et al. Thyrotropin-releasing hormone reduces myo-inositol contait in rat cerebellum pre-treated with lithium. J Neurochem 1987;49:88-91. (Pubitemid 17108233)
4. Gilman S, Low PA, Quinn N, et al. Consensus statement on the diagnosis of multiple system atrophy. J Neurol Sci 1999;163:94-98. (Pubitemid 29155424)
5. Delwaide PJ, Schoenen J, Dubois V, Belgium L. Thyrotropin releasing hormone (TRH) increases excitability of human motoneurons as tested by the F wave. Neurology 1984;34 (Suppl 1):284.
6. Raffaele R, Consentino E, Anicito MB, et al. Effects of TRH-T on spinal motoneurones in man. Neuropharmacol Neurotoxicol 1992;3:1017-1018.
7. Mitsumoto H, Salgado ED, Negroski D, et al. Double-blind, crossover trials with chronic, subcutaneous injections of small doses of TRH in patients with ALS. Neurology 1985;35 (Suppl 1):71.